Recent Blog Articles
The popularity of microdosing of psychedelics: What does the science say?
Pouring from an empty cup? Three ways to refill emotionally
Is pregnancy safe for everyone?
New pediatric guidelines on obesity in children and teens
Screening tests may save lives — so when is it time to stop?
Natural disasters strike everywhere: Ways to help protect your health
The case of the bad placebo
Do we feel pain more at night?
If you use cannabis, do it safely
Time for a diabetes tune-up
Harvard Health Blog
Read the latest posts from experts at Harvard Health Publishing covering a variety of health topics and perspectives on medical news.
A patient’s story: Overcoming incontinence
How one man persisted for almost two years in an effort to remedy one of the most bothersome possible side effects of prostate cancer treatment, and what men facing therapeutic decisions can learn from his experience.
Androgen-independent prostate cancer
When cancer advances despite primary hormone therapy
We often hear the term prostate cancer and assume it is one disease. Practically speaking, it is. On a molecular level, however, scientists are revealing a far more complex picture. Cancer has an innate ability to adapt to its surroundings. As it progresses, cancer cells tend to change, morphing to a point where the differences between tumor cells can be dramatic. That’s why some researchers believe late-stage prostate cancer is more accurately described as a mix of cancer cell types.
Answering key clinical questions
An interview with renowned urology researcher E. David Crawford, M.D., about the state of clinical trials on prostate health
Can hormone therapy extend the lives of men with advanced prostate cancer? Might a drug traditionally prescribed to treat benign prostatic hyperplasia (BPH) help prevent prostate cancer? Does a short course of hormone therapy prior to a radical prostatectomy prevent or delay cancer’s return?
Promising technologies for the treatment of prostate cancer
Marc B. Garnick, M.D., provides an overview of possible treatments that need more study, including cryotherapy, HIFU, and focal therapies.
How to handle a relapse after treatment for prostate cancer
Marc B. Garnick, M.D., discusses what biochemical recurrence means and what your options are.
Early-stage prostate cancer: Treat or wait?
When it comes to early-stage prostate cancer, there is no evidence that one treatment is better than another or that any treatment at all actually prolongs life. If you are diagnosed with early-stage prostate cancer, you’ll want to consider factors such as your values, your quality of life, and the potential side effects of various treatments before making a decision.
Getting a closer look at prostate cancer with molecular imaging
Molecular imaging may help determine the location and extent of cancer — and point to the best treatment — especially metastatic cancers too small to be detected by CT or MRI scanning.
Understanding your prostate pathology report
Not all pathology reports are created equal. In fact, they can vary widely even within a single institution. Learn what your report should contain, what it means, and why asking questions about it can lead to better care.
Improved magnetic resonance imaging (MRI) may aid detection of prostate cancer
Dr. Neil Rofsky, of Harvard’s Beth Israel Deaconess Medical Center, discusses MRI technology, which patients might benefit from it, and the relative advantages and disadvantages of MRI as compared with other imaging modalities.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!